Thomas Ramdahl
Director/Board Member chez CLARITY PHARMACEUTICALS LTD
Fortune : 935 829 $ au 31/03/2024
Profil
Thomas Ramdahl is currently the Chairman at Precirix NV, Chairman at Appsens AS, and Non-Executive Director at Clarity Pharmaceuticals Ltd.
He previously held positions as the Chief Executive Officer at Bayer AS, Director at Omegatri AS, Non-Executive Director at Nordic Nanovector ASA, Principal at Norsk Hydro ASA, Senior Vice President-Operations at Pronova BioPharma ASA, and Chief Technology Officer & Executive VP at Algeta ASA. Dr. Ramdahl obtained a doctorate degree from the University of Oslo in 1984 and a graduate degree from the Norwegian University of Science & Technology in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/03/2024 | 521 615 ( 0,19% ) | 935 829 $ | 31/03/2024 |
Postes actifs de Thomas Ramdahl
| Sociétés | Poste | Début |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Director/Board Member | 01/03/2019 |
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | Chairman | - |
Appsens AS
 Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | Chairman | - |
Anciens postes connus de Thomas Ramdahl
| Sociétés | Poste | Fin |
|---|---|---|
| THOR MEDICAL | Director/Board Member | 03/01/2023 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Operating Officer | 01/01/2001 |
Bayer AS
 Bayer AS Pharmaceuticals: MajorHealth Technology Bayer AS trades pharmaceutical products. It also provides animal health, crop science, and consumer health. The company was founded in 1964 and is headquartered in Lysaker, Norway. | Chief Executive Officer | - |
| NORSK HYDRO ASA | Corporate Officer/Principal | - |
Omegatri AS
 Omegatri AS Food: Specialty/CandyConsumer Non-Durables Omegatri AS develops tablets and powders containing Omega-3 for the health and food industry. Its products include unique administration from for omega-3, no reflux, high oxidative stability, proven bioavailability, IP protected formulation, no gelation and no lactose. The company was founded by Jo Erik Johnsrud Klaveness and Pal Rongved in 2007 and is headquartered in Oslo, Norway. | Director/Board Member | - |
Formation de Thomas Ramdahl
| University of Oslo | Doctorate Degree |
| Norwegian University of Science & Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NORSK HYDRO ASA | Non-Energy Minerals |
| CLARITY PHARMACEUTICALS LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
Omegatri AS
Omegatri AS Food: Specialty/CandyConsumer Non-Durables Omegatri AS develops tablets and powders containing Omega-3 for the health and food industry. Its products include unique administration from for omega-3, no reflux, high oxidative stability, proven bioavailability, IP protected formulation, no gelation and no lactose. The company was founded by Jo Erik Johnsrud Klaveness and Pal Rongved in 2007 and is headquartered in Oslo, Norway. | Consumer Non-Durables |
Bayer AS
Bayer AS Pharmaceuticals: MajorHealth Technology Bayer AS trades pharmaceutical products. It also provides animal health, crop science, and consumer health. The company was founded in 1964 and is headquartered in Lysaker, Norway. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Precirix NV develops and distributes radio-immunotherapeutic drugs for cancer patients. The company was founded on October 14, 2014 by Jens De Vos, Ludwig Camusot, Nick Devoogdt, Geert Raes, Tony Lahoutte and Matthias Dhuyvetter and is headquartered in Brussels, Belgium. | Health Technology |
Appsens AS
Appsens AS Medical SpecialtiesHealth Technology Appsens AS is a Norwegian company that develops, produces, and distributes the heart sensor ECG247. The company is based in Lillesand, Norway. The technology behind ECG247 is the result of many years of research in technology and has extensive clinical documentation of usability and accuracy. The company's technology consists of advanced algorithms, cloud-based data processing, and the use of artificial intelligence. The company was founded in 2017, and the CEO is Tord Ytterdahl. | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
